Top 10 FDI sectors: country-specific strategies, a game-theory frame, and the official tariff timeline
Extends the original 5-sector FDI framework to 10 by adding two ground-floor sectors (Inorganic Chemicals, Plastics — already Tier-1 in this repo's import-substitution ranking) plus Medical Devices and Aircraft & Spacecraft, and one honest non-finding (Textiles & Apparel). For every sector, real target FDI-source countries with sourced evidence — not a generic "attract FDI" list. Frames India's emerging use of volume quotas (not just tariffs) through a Generalized Nash Equilibrium tariff-rate-quota model, and lays out the dated arc of official 2025-2026 tariff actions that context depends on.
SOURCES: multi-agent research across 10 sectors, each cross-checked against a primary source (PIB, ministry release, investor disclosure, or the announcing government's own text) plus one corroborating source. Deals at MOU/framework stage are explicitly labeled as such. Game-theory framework: Passacantando & Raciti, Journal of Dynamics and Games, Apr 2025, DOI 10.3934/jdg.2025011. Retrieved 2026-07-19.
Generalized Nash Equilibrium / tariff-rate-quota model
Passacantando, M. & Raciti, F. — "A game theory model of tariff rate quotas in international trade." Journal of Dynamics and Games, April 2025. DOI 10.3934/jdg.2025011.
The paper models a tariff-rate quota as a Generalized Nash Equilibrium Problem: several exporting firms compete for access to several importing countries, each of which sets a two-tier duty — low below a volume threshold, high above it. Because the quota is shared, one firm's available volume depends on how much the others take, which is what makes it a genuine multi-firm game rather than a simple price response. The model proves an equilibrium exists and is unique under mild conditions, and its numerical experiments show the core trade-off an importing country faces: raising the threshold lifts tariff revenue but squeezes exporters' profits, while a strict quota reallocates market access in a way a tariff alone cannot.
Why this matters here: India's own trade policy has started reaching for exactly this instrument — a volume cap paired with a differential duty regime, not a flat tariff — in several of the sectors below. That makes the GNEP frame directly applicable: India is the quota-setting importer, and the supplier base in sectors like AC compressors (dominated by one or two firms) is playing a real multi-firm competition for a shared, capped quota.
Illustrative case — DPIIT Quality Control Order amendment on AC compressors, May 2026
MechanicsImport volumes capped at 30% of FY2025 volume for rotary/AC compressors (<2TR) and 40% for reciprocating/refrigerator compressors, layered on existing BIS certification requirements.
Stated intentExplicit government framing that China-based compressor makers — the market is dominated by GMCC (Guangdong Meizhi) — "cannot [continue selling into India] unless they build factories in India."
GNEP readIndia has substituted an absolute quota for the paper's "high tariff above threshold" tier — a firm exceeding the cap can't simply pay its way past it. The paper's own experiments show this produces a sharper market-access reallocation than a tariff-only TRQ. Predicted equilibrium response: GMCC and peers either build or expand India-based production (converting export volume into FDI — the explicit policy goal), or cede share to whoever can operate inside the cap, domestic (Amber Enterprises, Epack) or third-country (Korea-linked supply chains).
Second instance — India's own steel safeguard duty, in force through 2028
Mechanics12% safeguard duty on flat steel imports (stepping to 11.5%, then 11%), explicitly naming China, Japan, Korea, Vietnam and Nepal.
Strategic tensionJapan and Korea are simultaneously the two most credible FDI-source countries for specialty-steel technology transfer (see sector 02 below) and named targets of this same duty. The GNEP frame predicts this isn't a contradiction — the duty is the mechanism pushing Japanese/Korean capacity toward Indian joint ventures (JFE's Nashik acquisition, the POSCO-JSW JV) rather than continued arm's-length exports. A duty aimed at a country and FDI courtship of that country are often the same move, not opposing ones.
Official tariff timeline (2025 – present)
Confirmed government/court actions only — no speculation
Date
Event
2025 – early 2026
US "reciprocal tariff" regime under IEEPA imposed and repeatedly revised on India, ranging 26%–50% across the year, including a punitive tier tied to India's continued purchases of Russian crude.
2026-02-20
US Supreme Court strikes down the entire IEEPA reciprocal-tariff framework as exceeding executive authority. Every India-specific reciprocal rate issued under it is voided.
2026-02-20 →
Replaced, as an interim measure, with a flat global 10% Section 122 surcharge — applies uniformly to all trading partners, not India-specific, capped in duration by statute.
2026-07-24
The flat 10% Section 122 surcharge is due to expire by statutory limit (5 days from this report's retrieval date) unless extended or replaced — the single most consequential near-term date in the current picture.
2026-07-06 (comment period closed)
A proposed 12.5% Section 301 tariff explicitly naming India is pending as the intended replacement once Section 122 lapses. Not yet in force as of retrieval.
2025-06
Section 232 tariff of 50% on steel and aluminum, applied globally — no India-specific exemption negotiated.
2025 – 2026
Section 232 tariff of 25% on semiconductors, narrowly scoped to AI-accelerator chips; India not specifically named.
2025 – 2026
Section 232 tariff of 100% on patented/branded pharmaceuticals — generics and biosimilars explicitly excluded "at this time."
2026-02 (proposed, not implemented)
A tariff-rate-quota carve-out for Indian auto parts was discussed in a bilateral framework — NOT published or implemented as an actual rate as of retrieval.
ongoing, 2025 – 2026
India–US Bilateral Trade Agreement (BTA) remains unsigned despite multiple negotiating rounds; no finalized market-access commitments either side.
ongoing
US–China tariffs remain separately in force at Section 301 levels (~25%/7.5% List tiers, plus 100% EVs / 50% semiconductors / 50% solar) — unaffected by the IEEPA ruling, so this wall persists even as the India reciprocal-tariff layer was struck down.
2026-01-01
EU CBAM definitive period begins on schedule — covers iron/steel, aluminium, cement, fertilizer, hydrogen, electricity. Directly exposes ~$20.7bn of India's HS72/73 steel exports.
2026-05
India's own DPIIT QCO amendment imposes 30–40% import volume quotas on AC/refrigerator compressors (see game-theory case above).
ongoing through 2028
India's own steel safeguard duty (12% → 11%) remains in force against China, Japan, Korea, Vietnam and Nepal.
Cross-cutting observation
Because the entire 2025-era reciprocal-tariff schedule was voided, the widely-cited "India lost competitiveness to Vietnam/Bangladesh because of a higher reciprocal tariff rate" narrative is currently moot — Vietnam's 20% and Bangladesh's ~19% baseline were struck down in the same ruling, and all three now face the identical flat 10% Section 122 surcharge. Any sector strategy resting on a presumed India-vs-Vietnam tariff gap needs re-checking once (if) the Section 301 replacement actually takes effect on 2026-07-24.
China+1 — the government's own honest finding
NITI Aayog's own published assessment states China+1 diversification has had "limited success so far" for India specifically — Vietnam, Thailand, Cambodia and Malaysia have captured a larger share of the relocation away from China than India has. That's the government's own admission, not an external critique, and it should temper any narrative below that assumes India is the default China+1 beneficiary.
01. Electronics & Semiconductor Manufacturing
HS 84–85PLI Electronics + ISM 2.0 — strong
Taiwan
Process-technology / equipment partner, not primarily a capital source — the model is transferring fab IP while India and partners fund capex.
Tata Electronics–PSMC Dholera fab, Rs 91,000cr (~$11bn); trial production targeted Dec 2026.
Japan
The only target with a treaty-level government-to-government mechanism specific to this sector.
MeitY–METI Memorandum of Cooperation, Jul 2023, operationalized via the India-Japan Industrial Competitiveness Partnership (IJICP).
USA
Equipment and advanced-materials supply chain, under a bilateral tech-security dialogue rather than an investment mechanism.
iCET (Initiative on Critical and Emerging Technology) and the follow-on TRUST framework.
Tariff relevanceSection 232 semiconductor tariff (25%) is narrowly scoped to AI-accelerator chips and does not name India — limited direct exposure for this sector's current PLI-covered product base.
Flagged
The Vedanta-Foxconn Dholera JV collapsed July 2023 (Foxconn exited) — do not cite as active.
02. Specialty Steel & Metals
HS 72–73PLI Specialty Steel — strong
Japan
Direct technology transfer for electrical/specialty steel grades — via acquisition of an existing India-based asset, not a greenfield JV.
Process-equipment suppliers (Danieli, SMS group) sell into Indian expansions but hold no equity — a different relationship type from Japan/Korea.
Ongoing equipment-supply contracts tied to PLI-backed capacity expansion; no equity stake identified.
Tariff relevanceDirect tension with India's own steel safeguard duty (through 2028, targeting China/Japan/Korea/Vietnam/Nepal) and the EU CBAM definitive period from Jan 2026 on the export side — see the game-theory "second instance" above and the $20.7bn CBAM exposure figure in the companion sector file.
Flagged
Germany is exiting, not entering, this sector — thyssenkrupp's Nashik divestiture to JFE is an exit, not an investment.
03. Auto, EV & Battery
HS 87PLI Auto + ACC Battery — strong
Korea
The strongest, most diversified relationship: equipment flowing into India's own gigafactory buildout plus active cell-tech talks, reinforced by an upgraded trade pact.
Equipment into Agratas' (Tata) gigafactory; LG Energy Solution–JSW cell-technology talks; India-Korea CEPA upgrade negotiations.
Japan
The largest single committed capital figures in the sector, via the same IJICP mechanism used for electronics.
Toyota, $1.9bn; Suzuki, Rs 70,000cr (~$8.3bn at period-matched FY24-25 rate).
Not a target — a complicationChina: India's EV/battery buildout remains structurally dependent on Chinese graphite, lithium-compound and rare-earth supply even while India actively courts Korean and Japanese battery capital — an upstream-input dependency, not an FDI opportunity.
Tariff relevanceUS Section 232 auto tariff (25%) is global, not India-specific; a proposed TRQ carve-out for Indian auto parts was discussed Feb 2026 but not published or implemented.
Flagged
Tata's and Reliance's battery-technology partners are not yet confirmed in public disclosures — don't cite specific cell-chemistry licensors as settled.
The strongest live driver — a US domestic policy shift pushing biologics/CDMO manufacturing away from China toward alternative sourcing including India.
BIOSECURE Act-driven CDMO relocation; Eli Lilly, $1bn; Amgen, $200m.
Germany
A weak, adjacent-only relationship — flagged honestly rather than inflated.
Miltenyi Biotec has adjacent biotech activity in India; no confirmed bulk-drug-API-specific investment identified.
Reversed assumption — IsraelThe commonly assumed direction runs backward: Sun Pharma (Indian) acquired Israel's Taro Pharmaceutical — Indian capital flowing into Israel, not the reverse. Do not cite Israel as an FDI-source country for this sector.
Tariff relevanceUS Section 232 pharma tariff is 100% but explicitly excludes generics and biosimilars "at this time" — a genuine strategic opening given India's generics-dominant export profile, and the one clearly favorable current tariff carve-out in this whole analysis.
Flagged
China API dependency for Indian bulk-drug manufacturing runs closer to ~74% by value for the most critical KSMs, not the commonly cited 65-70% range.
05. White Goods Components
HS 84 (subset)PLI White Goods — fully subscribed, 85/85 slots
Japan
Most active investor by count and recurring commitment — market leader plus a compressor-specific supplier.
Daikin, Rs 547cr + a further Rs 1,400cr expansion; Nidec/Embraco compressor manufacturing.
Korea
Both major Korean appliance majors have live committed capital in this exact PLI window.
Samsung, $205.7m; LG Electronics, additional committed capacity.
Denmark
A concentrated, component-specific (compressors/controls) relationship rather than a broad appliance-brand presence.
Danfoss, Rs 500cr+ cumulative.
Tariff relevanceDirectly implicated by the May 2026 DPIIT compressor QCO quota (see game-theory case above) — Japan (Nidec/Embraco) and Korea are the compressor-technology partners best positioned to absorb the quota-driven localization the policy is designed to force.
06. Inorganic Chemicals
HS 28No PLI — ground-floor ($14.2bn imports, +86.0%)
Japan
The clearest sector-specific commitments identified, from two distinct majors, part of a broader post-China-plus-one pivot to India.
Sumitomo Chemical and Mitsubishi Gas Chemical facility commitments.
Germany
A real but general "Focus on India" corporate strategy commitment, not chemical-specific — directional interest, not a landed project.
Lanxess, Rs 750cr cumulative; BASF and Evonik have broader India activity, nothing inorganic-chemicals-specific identified.
Flagged
No PLI scheme exists here at all — any country pitch is necessarily "why invest ahead of the incentive," not "come collect the subsidy."
07. Plastics
HS 39No PLI — ground-floor ($22.2bn imports, +45.8%)
Saudi Arabia & UAE
The single largest headline commitment in this whole analysis by dollar value — still at MOU stage, not financial close.
Aramco/ADNOC-backed Ratnagiri Refinery & Petrochemicals (RRPCL), $44bn proposed, stalled at MOU stage as of retrieval.
Qatar
A broad, non-petrochemical-specific capital commitment — a directional signal, not a sector-specific project.
Qatar's broader $10bn India investment commitment; no petrochemical-specific allocation confirmed.
Japan
A specific, named, but pre-final-investment-decision project.
Mitsubishi Chemical MMA plant, pre-FID as of retrieval.
Flagged
RRPCL's $44bn figure has circulated publicly for years without financial close — never present it as committed capital without the MOU-stage caveat.
08. Aircraft & Spacecraft
HS 88No PLI — ground-floor ($13.8bn imports, +80.9%)
France
The only fully operating, financially-closed foreign manufacturing investment in this sector, plus a second live MRO/JV track.
The largest count of live engagements — engine co-production (not yet signed), an engineering center, a manufacturing JV, and an already-high-localization program.
GE-HAL F414 co-production discussed, NOT signed. Boeing $200m+ engineering center; Tata-Boeing JV; Lockheed C-130J already at 96% local content.
Israel
A newly signed defense-adjacent JV, distinct from the civil-aviation relationships above.
IAI-DCX radar joint venture, signed May 2026.
Flagged
The GE-HAL F414 engine deal is frequently reported as done — it is a discussed co-production arrangement, NOT a signed agreement, as of retrieval.
09. Medical Devices
HS 90 (subset)PLI Medical Devices — partial, Rs 3,420cr
Germany
The most-cited landed investment in the sector, though the commitment predates this PLI window — flagged for vintage, not presented as a fresh signal.
Siemens Healthineers, €160m — 2020-vintage, still the reference investment, in production under the PLI umbrella.
Japan
An R&D-specific commitment paired with a newly opened research-cooperation mechanism.
Olympus R&D center; new AMED-ICMR (Japan-India) Memorandum of Cooperation, Aug 2025.
USA
The two largest dollar commitments in the sector — one direct manufacturer investment, one JV-structured deal.
Medtronic, $350m; GE Healthcare-Wipro JV, Rs 8,000cr.
HS 61–62PLI Textiles — mismatched (targets MMF, not cotton)
Honest finding: no credible FDI-source country was identified for this sector. PLI Textiles (Rs 10,683cr) targets man-made fibre and technical textiles, structurally excluding the cotton-based apparel that makes up the declining export chapters (HS 61/62, -2.3% and -2.0% growth). The dominant real capital movement here is Indian-owned capacity returning to India from Bangladesh — a reshoring move by Indian textile groups themselves, not inbound foreign investment. A country-strategy pitch for this sector would be fabricating a relationship the evidence doesn't support. The fix, per this repo's original recommendation, is broadening PLI Textiles' scope to cotton apparel — not a country-targeting pitch.
Tariff relevanceShares the same voided-reciprocal-tariff arc as every export chapter — the assumed India-vs-Vietnam-vs-Bangladesh competitiveness gap is currently moot since all three now face the same flat 10% Section 122 surcharge.
Deals at MOU/framework stage are labeled as such, not presented as landed capital — most visibly the $44bn RRPCL petrochemical project (Plastics) and the GE-HAL F414 engine deal (Aircraft & Spacecraft), both still short of financial close or signature as of retrieval.
Two corrections to earlier assumptions surfaced in this research pass: Germany is exiting (not entering) Specialty Steel via thyssenkrupp's Nashik divestiture; Israel's pharma relationship runs the opposite direction (Sun Pharma acquired Taro, not the reverse).
Textiles & Apparel is deliberately left with no target countries — see sector 10 above. This is a finding, not a gap in the research.
The tariff timeline is restricted to confirmed government/court actions — proposed-but-not-implemented items (the Section 301 replacement, the auto-parts TRQ carve-out) are explicitly marked as pending, not in force.